secondary metabolites – Page 8

Aspergillus terreus IFM 65899-THP-1 cells interaction triggers production of the natural product butyrolactone Ia, an immune suppressive compound

mycolabadmin

Scientists discovered that when a dangerous fungus called Aspergillus terreus is grown together with immune cells, it produces a special compound called butyrolactone Ia that helps it hide from the body’s defense system. This compound works by reducing inflammatory signals that immune cells use to fight the fungus. The research shows that direct contact between the fungus and immune cells is needed to trigger this protective compound production, suggesting the fungus responds directly to the threat of immune attack.

Antifungal effects of metabolites from Arthrinium sp. 2–65 and identification of main active ingredients

mycolabadmin

Scientists discovered that a fungus called Arthrinium sp. 2–65, found living inside a wild plant called Thymus mongolicus, produces two special compounds that can kill the fungus responsible for grey mould disease. Grey mould is a major problem for farmers worldwide, damaging crops like tomatoes, grapes, and strawberries. These newly identified compounds were tested and showed excellent effectiveness against the disease, offering a promising natural alternative to chemical pesticides that have become less effective due to resistance and environmental concerns.

Haplotype-Phased Chromosome-Level Genome Assembly of Floccularia luteovirens Provides Insights into Its Taxonomy, Adaptive Evolution, and Biosynthetic Potential

mycolabadmin

Scientists have created the most detailed genetic map of the yellow mushroom (Floccularia luteovirens), a highly valued medicinal and edible fungus from the Tibetan Plateau. Using advanced sequencing technology, they mapped its 13 chromosomes and identified 15 pathways that the mushroom uses to make potentially useful healing compounds. The research also solved a long-standing mystery about the mushroom’s family tree, proving it is not actually related to Armillaria mushrooms as previously thought. This genetic blueprint opens new possibilities for developing medicines from this special fungus.

Integrated Transcriptomics and Metabolomics Provide Insight into Degeneration-Related Molecular Mechanisms of Morchella importuna During Repeated Subculturing

mycolabadmin

This study explains why morel mushroom strains weaken when repeatedly grown in laboratories. Researchers found that degenerated strains lose the ability to produce protective compounds called flavonoids, which act as natural antioxidants. By understanding these molecular changes, the researchers suggest that avoiding frequent subculturing and using preservation methods like low-temperature storage could help keep morel strains healthy and productive.

Biology and Application of Chaetomium globosum as a Biocontrol Agent: Current Status and Future Prospects

mycolabadmin

Chaetomium globosum is a fungus that can protect crops from various plant diseases by producing toxic compounds and parasitizing harmful pathogens. It also helps plants defend themselves naturally and improves soil health by promoting beneficial microorganisms. This makes it a promising alternative to chemical pesticides for sustainable farming, though more research is needed to optimize its effectiveness in real field conditions.

New bioactive secondary metabolites from fungi: 2024

mycolabadmin

Scientists discovered 907 new compounds from fungi in 2024, with most being terpenoids and polyketides that show promise as medicines. These fungal compounds demonstrate strong activity against bacteria, fungi, and inflammation, with some showing potential against cancer and diabetes. The research uses advanced techniques like genome mining and metabolomics to find these compounds more efficiently. This accelerating discovery rate suggests fungi could be a major source for developing new drugs to treat various diseases.

Genomic insights into the ecological versatility of Tetracladium spp

mycolabadmin

Researchers sequenced the genomes of two fungal species called Tetracladium that live in different environments – one found in plant roots and one from freshwater. These fungi have special enzymes that allow them to break down plant cell walls and materials, enabling them to survive in multiple habitats. The study revealed these fungi can also produce compounds with potential medical properties like antifungal and antibacterial effects.

Streptomyces-Based Bioformulation to Control Wilt of Morchella sextelata Caused by Pestalotiopsis trachicarpicola

mycolabadmin

Researchers isolated two beneficial bacteria strains (Streptomyces) from soil around morel mushrooms that can effectively fight a fungal disease causing morel wilting. These bacteria produce natural compounds that kill the disease-causing fungus while also promoting healthier mushroom growth. When used in field tests, these bacterial treatments reduced disease and increased morel yield by nearly 30% compared to untreated crops, offering an eco-friendly alternative to chemical fungicides.

Production of fungal hypocrellin photosensitizers: Exploiting bambusicolous fungi and elicitation strategies in mycelium cultures

mycolabadmin

Hypocrellins are powerful compounds from fungi that can treat cancers and infections through light-activated therapy. Since wild sources are limited, scientists are growing these fungi in laboratory cultures and using special techniques to boost production. This review summarizes the best methods for producing hypocrellins, from choosing the right fungal strains to optimizing growing conditions and using natural stimulants to increase yields.

Localization of Secondary Metabolites in Relict Gymnosperms of the Genus Sequoia In Vivo and in Cell Cultures In Vitro, and the Biological Activity of Their Extracts

mycolabadmin

Researchers studied an ancient giant redwood tree species to extract valuable medicinal compounds. They successfully grew Sequoia cells in laboratory culture that produced powerful cancer-fighting and antifungal substances. These extracts showed promise against cervical cancer and brain tumor cells while being safe to normal cells, offering a sustainable way to harvest these compounds without damaging wild redwood populations.

Research Topic: secondary metabolites